Yingjin Qiao

1.2k total citations · 1 hit paper
28 papers, 876 citations indexed

About

Yingjin Qiao is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingjin Qiao has authored 28 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 12 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingjin Qiao's work include Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (7 papers) and Ferroptosis and cancer prognosis (6 papers). Yingjin Qiao is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (7 papers) and Ferroptosis and cancer prognosis (6 papers). Yingjin Qiao collaborates with scholars based in China, United States and Sweden. Yingjin Qiao's co-authors include Zhangsuo Liu, Shaokang Pan, Dongwei Liu, Qi Feng, Pei Wang, Bohan Chen, Jiayu Duan, Xianhui Liang, Lan Yao and Rujun Gong and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Journal of the American Society of Nephrology.

In The Last Decade

Yingjin Qiao

26 papers receiving 874 citations

Hit Papers

Mitochondrial dysfunction in diabetic tubulopathy 2022 2026 2023 2024 2022 25 50 75 100

Peers

Yingjin Qiao
Yingjin Qiao
Citations per year, relative to Yingjin Qiao Yingjin Qiao (= 1×) peers Miguel Fontecha‐Barriuso

Countries citing papers authored by Yingjin Qiao

Since Specialization
Citations

This map shows the geographic impact of Yingjin Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjin Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjin Qiao more than expected).

Fields of papers citing papers by Yingjin Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjin Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjin Qiao. The network helps show where Yingjin Qiao may publish in the future.

Co-authorship network of co-authors of Yingjin Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjin Qiao. A scholar is included among the top collaborators of Yingjin Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjin Qiao. Yingjin Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Y., Shaokang Pan, Qing Zhang, et al.. (2025). The Gut–Kidney Dialogue: Unraveling the Microbial Symphony in Renal Fibrosis. The FASEB Journal. 39(20). e71179–e71179.
2.
Liu, Yong, Shaokang Pan, Duo Chen, et al.. (2025). Epigenetic Regulation of Ferroptosis in Chronic Kidney Disease: Mechanisms and Implications. Research. 8. 934–934.
3.
Chen, Jingfang, Qi Feng, Yingjin Qiao, et al.. (2024). ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes. Diabetologia. 67(7). 1429–1443. 28 indexed citations
4.
Feng, Qi, Yang Yang, Kaidi Ren, et al.. (2023). Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases. International Journal of Biological Sciences. 19(12). 3726–3743. 40 indexed citations
5.
Duan, Jiayu, Shaokang Pan, Fei Cheng, et al.. (2023). The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis. Cell Death and Disease. 14(7). 426–426. 60 indexed citations
6.
Feng, Qi, Xiaoyue Yu, Yingjin Qiao, et al.. (2022). Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials. Frontiers in Pharmacology. 13. 858676–858676. 82 indexed citations
7.
Yao, Lan, Xianhui Liang, Yingjin Qiao, et al.. (2022). Mitochondrial dysfunction in diabetic tubulopathy. Metabolism. 131. 155195–155195. 117 indexed citations breakdown →
8.
Li, Shiyang, Rui Wang, Yong Liu, et al.. (2022). Ferroptosis: A new insight for treatment of acute kidney injury. Frontiers in Pharmacology. 13. 1065867–1065867. 25 indexed citations
9.
Yao, Lan, et al.. (2022). Effects of salvianolic acid A and salvianolic acid B in renal interstitial fibrosis via PDGF-C/PDGFR-α signaling pathway. Phytomedicine. 106. 154414–154414. 18 indexed citations
10.
Guo, Jia, Xiaoqing Lu, Yingjin Qiao, et al.. (2022). cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1. Metabolism. 129. 155155–155155. 32 indexed citations
11.
Pan, Shaokang, Zhengyong Li, Yixue Wang, et al.. (2022). A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease. Journal of Translational Internal Medicine. 0(0). 1 indexed citations
12.
Zhao, Huanhuan, Lulu Liang, Shaokang Pan, et al.. (2021). Diabetes Mellitus as a Risk Factor for Progression from Acute Kidney Injury to Acute Kidney Disease: A Specific Prediction Model. Diabetes Metabolic Syndrome and Obesity. Volume 14. 2367–2379. 8 indexed citations
13.
Liu, Fengxun, Jia Guo, Yingjin Qiao, et al.. (2021). MiR‐138 plays an important role in diabetic nephropathy through SIRT1–p38–TTP regulatory axis. Journal of Cellular Physiology. 236(9). 6607–6618. 12 indexed citations
14.
Liu, Dongwei, Yingjin Qiao, Xuan Zheng, et al.. (2020). <p>Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma</p>. Cancer Management and Research. Volume 12. 11783–11791. 6 indexed citations
15.
Yu, Qi, Yingjin Qiao, Dongwei Liu, et al.. (2019). Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy. Arthritis Research & Therapy. 21(1). 19–19. 31 indexed citations
16.
Duan, Jiayu, Chongjian Wang, Dongwei Liu, et al.. (2019). Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Scientific Reports. 9(1). 10408–10408. 102 indexed citations
17.
Qiao, Yingjin, Chunming Jiang, Yan Ge, et al.. (2019). GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition. Redox Biology. 26. 101275–101275. 86 indexed citations
18.
Shi, Yan, Jiayu Duan, Dongwei Liu, et al.. (2018). Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients. Chinese Medical Journal. 131(22). 2734–2740. 15 indexed citations
19.
Qiao, Yingjin, Pei Wang, Yan Ge, et al.. (2016). MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy. Scientific Reports. 6(1). 27589–27589. 22 indexed citations
20.
Guo, Jia, Lili Yang, Sijie Zhou, et al.. (2014). GSK-3� and Vitamin D Receptor are Involved in �-Catenin and Snail Signaling in High Glucose-Induced Epithelial-Mesenchymal Transition of Mouse Podocytes. Cellular Physiology and Biochemistry. 33(4). 1087–1096. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026